Ultragenyx Pharmaceutical (RARE) Q1 2020 Earnings

13FebConfirmed
May 19
Q3 2019
Q4 2019
Q1 2020
-1.96
-1.85
-1.73
-1.62

Details

Expected EPS
-1.66
Actual EPS
-1.62
Surprise EPS
0.04
Surprise Percent
+2.41%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.62 per share for Q1 2020.

0 Comments

Share your thoughts